Eventide Asset Management, LLC Aura Biosciences, Inc. Transaction History
Eventide Asset Management, LLC
- $5.67 Billion
- Q3 2024
A detailed history of Eventide Asset Management, LLC transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Eventide Asset Management, LLC holds 5,802,682 shares of AURA stock, worth $47.5 Million. This represents 0.91% of its overall portfolio holdings.
Number of Shares
5,802,682
Previous 5,802,682
-0.0%
Holding current value
$47.5 Million
Previous $43.9 Million
17.86%
% of portfolio
0.91%
Previous 0.77%
Shares
5 transactions
Others Institutions Holding AURA
# of Institutions
85Shares Held
37.6MCall Options Held
122KPut Options Held
38.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$56.6 Million2.94% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$39.9 Million0.08% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$24.9 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$24.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.81MShares$14.8 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $239M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...